SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
WASHINGTON, March 06, 2017 -- Surefire Medical, Inc. today announced the launch of the new Flexion Guiding Catheter at the Society for Interventional Radiology (SIR) meeting in Washington, DC. The device has a main curve reinforced with nitinol to provide better shape retention and back-up support for interventional radiologists performing embolization procedures.
In addition to the differentiated nitinol curve, the Surefire Flexion offers the following features:
- An inner diameter of 0.054 inches with a PTFE liner
- Soft radiopaque tip that facilitates vessel engagement and catheter placement
- Double-stranded steel braid for optimal kink resistance and torque response.
“This is truly an engineering breakthrough,” said James E. Chomas, President and CEO of Surefire Medical. “The nitinol reinforcement enables this device to keep a low 5F profile while providing physicians with maximum support during Surefire procedures, or any other procedures that would require a guide catheter with a large lumen. We are excited to launch this device and continue to demonstrate Surefire’s commitment to the interventional radiology market.”
The Surefire Flexion Guiding Catheter is available in two shapes – the Axis and SIM1. The company continues to offer the Surefire Cobra Guiding Catheter.
About Surefire Medical
Surefire Medical, Inc. develops, manufactures and markets targeted delivery devices for the Interventional Oncology markets. Surefire’s core technology consists of a microcatheter with a unique expandable tip that improves tumor uptake while protecting healthy tissue. It enables physicians to target tumors with superior accuracy, control and protection. Learn more: www.surefiremedical.com.
Media Contact: Jenna Clark Surefire Medical 303.717.2339 [email protected]
